Diagnostics Assessment Programme

This guidance evaluates new, innovative diagnostic technologies. It includes all types of measurements and tests that are used to evaluate a patient's condition.

Diagnostic technologies may be used for various purposes. These include:

  • ruling in or out a specific disease
  • general examination looking for clues to the cause of the symptoms
  • staging, or additional testing to assess how advanced or severe the disease is
  • monitoring a patient over time to determine changes in their condition
  • screening tests to look for conditions in patients without signs or symptoms of the specific condition.

Get a technology assessed

If you manufacture a diagnostic technology, you can ask us to consider it for guidance. We look at how it compares with technologies already available and if it offers advantages over current practice.

Tell us about your product

Diagnostics guidance

Our guidance helps people in the NHS make efficient, cost-effective and consistent decisions about adopting new products. It supports innovation, transformation and improves healthcare delivery.

View guidance

Static list

We regularly review our diagnostics guidance. If there is no new research or evidence available that would have a material effect on the guidance, it gets moved to the static list. If new evidence becomes available, the guidance can be transferred back to the active list for further appraisal.

The following guidance has been transferred to the static list.

RefTitleDate issuedReview decision
DG1 The EOS 2D/3D imaging system October 2011 DG1 Review decision
DG3 New generation cardiac CT scanners January 2012 DG3 Review decision
DG5 SonoVue (sulphur hexafluoride microbubbles) August 2012 DG6 Review decision
DG6 Depth of anaesthesia monitors - Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M November 2012 DG6 Review decision
DG8 Intraoperative tests (RD 100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer August 2013 DG8 Review decision
DG9 EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer August 2013 DG9 Review decision
DG11 Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel October 2013 DG11 Review decision
DG12 Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath April 2014 DG12 Review decision
DG14 Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) September 2014 DG14 Review decision
DG16 Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment December 2014 DG16 Review decision
DG19 VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions November 2015 DG19 Review decision
DG20 SepsiTest assay for rapidly identifying bloodstream bacteria and fungi February 2016 DG20 Review decision